Pulmonary embolism in COVID-19
COVID-19 pandemic is recognized as a present day major public health burden. Risk factors for developing a more severe course of COVID-19 include increased levels of C-reactive protein and D-dimer. Pulmonary embolism (PE) is challenging in patients with COVID-19. The purpose: to analyze clinical and...
Saved in:
Main Authors: | V. Ilyina-Stohniienko (Author), Yu. Kharchenko (Author), A. Zaretska (Author), A. Savchuk (Author), A. Kolotvin (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary embolism in an adolescent with COVID-19 pneumonia
by: Héctor Nuñez-Paucar, et al.
Published: (2023) -
Clinical and paraclinical manifestation COVID-19 in different age children
by: Yu.P. Kharchenko, et al.
Published: (2022) -
Treatment of pulmonary embolism in "fragile" patients
by: V. I. Golovina, et al.
Published: (2024) -
Distinct Coagulopathy With Myocardial Injury and Pulmonary Embolism in COVID-19
by: Ayman R. Fath MD, et al.
Published: (2021) -
Clomiphene- induced pulmonary embolism
by: Chahat Puri, et al.
Published: (2021)